← Leaderboards
Angray S Kang
Avanir Pharmaceuticals
$499,915
Attributed
$499,915
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$499,915 · 2
By mechanism
R43$499,915 · 2
Top collaborators
No co-investigators on record.
Most similar at Avanir Pharmaceuticals
Same institution · by research overlap
- Wolfgang W Scholz$5,224,945
- Phillip R Morrow$100,000
Others in their field
Top investigators on “Neutralizing Antibody”
- Barton F Haynes · Duke University$361,488,167
- Dennis R. Burton · Scripps Research Institute$328,455,703
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,392,049
- Lawrence Corey · Fred Hutchinson Cancer Center$257,355,255
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,509,763
Research focus
Neutralizing AntibodyImmunologic Substance Development /PreparationRecombinant ProteinsScid MouseMonoclonal AntibodyBioterrorism /Chemical WarfareCell LineClinical ResearchCombination ChemotherapyCytomegalovirusDisease /Disorder ModelDrug InteractionsEnzyme Linked Immunosorbent AssayExotoxinsHuman SubjectHuman TissueLaboratory RatMicroorganism Disease ChemotherapyMolecular CloningNonhuman Therapy EvaluationPassive ImmunizationPolymerase Chain ReactionProtein BindingAnthrax